Literature DB >> 8148214

The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomers.

U K Walle1, T C Fagan, M J Topmiller, E C Conradi, T Walle.   

Abstract

1. Plasma binding of tritium-labelled racemic propranolol (P) was measured by equilibrium dialysis. The unbound enantiomers were separated by h.p.l.c. after chiral derivatization. The binding of (-)-P was higher than that of (+)-P. 2. Contrary to previous suggestions, a sex difference in the plasma binding of the P enantiomers (9 young women, 12 young men) was not observed. The unbound percentage of (-)-P was 9.2 +/- 1.8 (mean +/- s.d.) in women vs 9.1 +/- 1.7 in men; for (+)-P it was 10.8 +/- 1.8 vs 10.8 +/- 2.1. 3. In the nine women, the binding did not change with fluctuating plasma oestradiol concentrations during the menstrual cycle. Testosterone cypionate doubled the circulating concentrations of testosterone in eight men but had no effect on P binding. 4. Ethinyl oestradiol (50 micrograms day-1) alone or together with norethindrone (OCD) in eight of the women produced an increase in the unbound percentage of both (-)-P (11.4 +/- 2.6 vs 9.5 +/- 1.6 for control; P < 0.001) and (+)-P (13.2 +/- 2.5 vs 11.2 +/- 1.5 for control; P < 0.001). This was due to a decrease in the plasma concentrations of alpha 1-acid glycoprotein from 0.54 +/- 0.11 mg ml-1 in control to 0.37 +/- 0.08 mg ml-1 (P < 0.001) during ethinyl oestradiol treatment. 5. Enantioselectivity in the unbound fraction of P increased with increasing total binding from a (-)/(+)-ratio of 0.93 at 84% binding to a (-)/(+)-ratio of 0.78 at 94% binding (P < 0.001).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8148214      PMCID: PMC1364704          DOI: 10.1111/j.1365-2125.1994.tb04233.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

1.  Variable binding of propranolol in human serum.

Authors:  G Sager; O G Nilsen; S Jacobsen
Journal:  Biochem Pharmacol       Date:  1979-03-15       Impact factor: 5.858

2.  Effect of administration of a combined estrogen-progestin contraceptive on the level of individual plasma proteins.

Authors:  C B Laurell; S Kullander; J Thorell
Journal:  Scand J Clin Lab Invest       Date:  1968       Impact factor: 1.713

3.  Separation of the enantiomers of intact sulfate conjugates of adrenergic drugs by high-performance liquid chromatography after chiral derivatization.

Authors:  T Walle; D D Christ; U K Walle; M J Wilson
Journal:  J Chromatogr       Date:  1985-05-31

4.  Determinants of plasma alpha 1-acid glycoprotein (AAG) concentrations in health.

Authors:  P G Blain; J C Mucklow; M D Rawlins; D F Roberts; P A Routledge; D G Shand
Journal:  Br J Clin Pharmacol       Date:  1985-11       Impact factor: 4.335

5.  Age and gender influence the stereoselective pharmacokinetics of propranolol.

Authors:  D A Gilmore; J Gal; J G Gerber; A S Nies
Journal:  J Pharmacol Exp Ther       Date:  1992-06       Impact factor: 4.030

6.  Changes in plasma drug binding and alpha 1-acid glycoprotein in mother and newborn infant.

Authors:  M Wood; A J Wood
Journal:  Clin Pharmacol Ther       Date:  1981-04       Impact factor: 6.875

7.  Binding of beta-adrenoceptor blocking drugs to human serum albumin, to alpha 1-acid glycoprotein and to human serum.

Authors:  F M Belpaire; M G Bogaert; M Rosseneu
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  Stereoselective binding of propranolol to human plasma, alpha 1-acid glycoprotein, and albumin.

Authors:  U K Walle; T Walle; S A Bai; L S Olanoff
Journal:  Clin Pharmacol Ther       Date:  1983-12       Impact factor: 6.875

9.  Different binding of propranolol enantiomers to human alpha 1-acid glycoprotein.

Authors:  J Oravcová; S Bystricky; T Trnovec
Journal:  Biochem Pharmacol       Date:  1989-08-15       Impact factor: 5.858

10.  Resolution of (+/-)-propranolol.

Authors:  Y Yost; J L Holtzman
Journal:  J Pharm Sci       Date:  1979-09       Impact factor: 3.534

View more
  6 in total

Review 1.  Gender-specific differences in the central nervous system's response to anesthesia.

Authors:  Lana J Mawhinney; Davita Mabourakh; Michael C Lewis
Journal:  Transl Stroke Res       Date:  2012-11-29       Impact factor: 6.829

Review 2.  How important are gender differences in pharmacokinetics?

Authors:  Bernd Meibohm; Ingrid Beierle; Hartmut Derendorf
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  Polyethylene glycol 400 enhances the bioavailability of a BCS class III drug (ranitidine) in male subjects but not females.

Authors:  Diane A I Ashiru; Rajesh Patel; Abdul W Basit
Journal:  Pharm Res       Date:  2008-07-04       Impact factor: 4.200

4.  Trauma reactivation under the influence of propranolol: an examination of clinical predictors.

Authors:  Joaquin Poundja; Steven Sanche; Jacques Tremblay; Alain Brunet
Journal:  Eur J Psychotraumatol       Date:  2012-02-14

5.  Does reconsolidation occur in humans?

Authors:  Daniela Schiller; Elizabeth A Phelps
Journal:  Front Behav Neurosci       Date:  2011-05-17       Impact factor: 3.558

6.  Estrogen Receptor-A in Medial Preoptic Area Contributes to Sex Difference of Mice in Response to Sevoflurane Anesthesia.

Authors:  Yunyun Zhang; Huiming Li; Xinxin Zhang; Sa Wang; Dan Wang; Jiajia Wang; Tingting Tong; Zhen Zhang; Qianzi Yang; Hailong Dong
Journal:  Neurosci Bull       Date:  2022-02-17       Impact factor: 5.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.